Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT02745756
Eligibility Criteria:
Inclusion Criteria:
* Must have a histological diagnosis of neuroblastoma or ganglioneuroblastoma and be either newly diagnosed with high risk disease or have failed previous treatment: Patients who have failed previous treatment may have had no more than one earlier autologous HPC transplant.
* Participant is expected to undergo autologous HPC transplantation that is consistent with standard of care.
* Must have the presence of residual resectable disease for which surgery is clinically indicated, and will be performed at Johns Hopkins All Children's Hospital.
Exclusion Criteria:
* Not an eligible candidate for collection by apheresis or HPC transplant.
* History of autoimmune disorder or immune deficiency disorder.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT02745756
Study Brief:
Protocol Section:
NCT02745756